Michael S. Avumegah
Oslo, 0277, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Clinical and microbiological features of critical Clade Ib mpox in adults with HIV during a Ugandan outbreak.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: April 16, 2026
Saliva versus lesion swabs for PCR diagnosis of acute-phase clade Ib mpox in Uganda: a prospective matched hospital cohort study.
Journal: The Lancet. Microbe
Published: December 14, 2025
Nipah virus destroyed my personal, family, and social life: stories of the hardship faced by Nipah survivors in Bangladesh.
Journal: International journal for equity in health
Published: December 07, 2025
Lesion viral burden, multidrug-resistant superinfection, and HIV-associated haematological vulnerability in hospitalised clade Ib mpox: a prospective cohort study in Uganda.
Journal: EBioMedicine
Published: November 14, 2025
Persistent T Cell Immunity Following Nipah Virus Infection: Evidence From Malaysian Survivors.
Journal: The Journal of infectious diseases
Published: September 19, 2025
Specimen and data sharing to advance research and development on Zika virus.
Journal: The Lancet. Microbe
Published: August 29, 2024
Malaysia outbreak survivors retain detectable Nipah antibodies and memory B cells after 25 years.
Journal: The Journal of infection
Published: August 16, 2024
Rapid diagnostic test: a critical need for outbreak preparedness and response for high priority pathogens.
Journal: BMJ global health
Published: November 01, 2023
Availability and use of Standards in vaccine development.
Journal: NPJ vaccines
Published: February 28, 2023
SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein.
Journal: Molecular psychiatry
Published: January 24, 2022
Preclinical development of a molecular clamp-stabilised subunit vaccine for severe acute respiratory syndrome coronavirus 2.
Journal: Clinical & translational immunology
Published: February 23, 2021
Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial.
Journal: The Lancet. Infectious diseases
Published: January 18, 2021
Last Updated: 09/26/2026